Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-76.72	1.24	5.33
Graham Fair Price	98.51	10.92	5.50
PEG	-93.06	0.02	-0.24
Price/Book	5.47	0.62	0.59
Price/Cash Flow	-32.66	26.45	-39.28
Prices/Earnings	-71.10	4.64	16.06
Price/Sales	-7.58	2.60	2.81
Price/FCF	-32.66	26.45	-39.28
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	295.49	0.19	0.05
Operating Margin	30.77	0.19	-0.15
ROA	280.02	0.01	< 0.005
ROE	< 0.005	0.03	265.01
ROIC	-0.02	0.03	44.92
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.27	-0.01	-2499.08
Dividends QOQ	2.84	-0.91	-68.11
EBIT QOQ	-1.78	2.54	42.85
EPS QOQ	-0.68	2.82	316.60
FCF QOQ	-1.67	2.62	57.21
Revenue QOQ	-0.04	0.18	322.96
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	15.19	14.99	-1.28
Days Sales Outstanding (DSO)	15.60	17.41	11.54
Inventory Turnover	5.93	6.00	1.30
Debt/Capitalization	0.30	0.23	-22.85
Quick Ratio	1.48	1.47	-0.55
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.14	12.61	3.91
Cash	11.22	10.85	-3.26
Capex	-0.31	-0.26	17.36
Free Cash Flow	-0.18	0.29	62.73
Revenue	2.53	3.00	18.58
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.59	1.57	-1.11
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-28.05	-11.32	59.64
Naive Interpretation	Member

06 - Financial Health · Weak

Rating